Showing results (151-160 of 194) with videos related to
Sort By:
Pageof 20
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 15, 2016
Remodeling of the Tumor Microenvironment Predicts Increased Risk of Cancer in Postmenopausal Women: The Prospective Epidemiologic Risk Factor (PERF I) StudyCecilie L Bager, Nicholas Willumsen, Stephanie N Kehlet, et al.Annals of the Rheumatic Diseases|November 3, 2012
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trialJean-Yves Reginster, Janusz Badurski, Nicholas Bellamy, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 15, 2010
Effects of denosumab on bone turnover markers in postmenopausal osteoporosisRichard Eastell, Claus Christiansen, Andreas Grauer, et al.Oncotarget|September 9, 2017
Excessive matrix metalloprotease-mediated degradation of interstitial tissue (type I collagen) independently predicts short-term survival in an observational study of postmenopausal women diagnosed with cancerNicholas Willumsen, Cecilie L Bager, Stephanie N Kehlet, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 8, 2012
Recommendations on the management of fragility fracture risk in women younger than 70 yearsSantiago Palacios, Claus Christiansen, Rafael Sánchez Borrego, et al.British Journal of Clinical Pharmacology|May 21, 2021
Safety, tolerability and pharmacokinetic characterisation of DACRA KBP-042 in healthy male subjectsKim Henriksen, Karen Broekhuizen, Wadim M I de Boon, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 23, 2013
RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular riskElizabeth J Samelson, Paul D Miller, Claus Christiansen, et al.Menopause (New York, N.Y.)|November 17, 2004
Changes in bone density and turnover after alendronate or estrogen withdrawalRichard D Wasnich, Yu Z Bagger, David J Hosking, et al.Scientific Reports|March 31, 2018
Matrix Metalloproteinase Mediated Type I Collagen Degradation is an Independent Predictor of Increased Risk of Acute Myocardial Infarction in Postmenopausal WomenDitte Marie Bertelsen, Jesper Skov Neergaard, Cecilie Liv Bager, et al.JAMA|August 18, 2016
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical TrialPaul D Miller, Gary Hattersley, Bente Juel Riis, et al.Pageof 20